Shilpa Medicare has acquired Pilnova Pharma, Inc in the United States on November 2, 2023, which will now be a wholly owned subsidiary of the company. The object of acquisition is to establish front end presence in the US Market with an objective to capture the full potential of its niche portfolios.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
